ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

HCM.GB HUTCHMED China Limited

304.74
-5.26 (-1.70%)
19:22:41 - 실시간 데이터
기업명 주식 심볼 시장 주식 타입
HUTCHMED China Limited HCM.GB Aquis 증권거래소 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-5.26 -1.70% 304.74 19:22:41
개장가 저가 고가 종가 전일 종가
310.00 304.74 310.00 310.00
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
11/01/202416:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
29/12/202317:30UKREGHutchmed (China) Limited Total Voting Rights
29/12/202317:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
21/12/202319:00UKREGHutchmed (China) Limited Overseas Regulatory Announcement
13/12/202316:00RNSNONHutchmed (China) Limited Inclusion in National Reimbursement..
07/12/202319:04UKREGHutchmed (China) Limited Overseas Regulatory Announcement
01/12/202316:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
30/11/202317:30UKREGHutchmed (China) Limited Total Voting Rights
09/11/202316:00UKREGHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..
24/10/202317:30UKREGHutchmed (China) Limited Vesting of awards under the LTIP
16/10/202317:30RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
29/09/202317:30RNSNONHutchmed (China) Limited NDA Submission for Fruquintinib in..
29/09/202317:30UKREGHutchmed (China) Limited Total Voting Rights
14/09/202317:30UKREGHutchmed (China) Limited Director's Share Dealing
12/09/202317:30RNSNONHutchmed (China) Limited Phase IIIb Savolitinib Results at..
12/09/202315:00RNSNONHutchmed (China) Limited Patient Enrollment Completed for..
31/08/202317:30UKREGHutchmed (China) Limited Total Voting Rights
29/08/202315:00RNSNONHutchmed (China) Limited BTD in China for Savolitinib for..
21/08/202315:00UKREGHutchmed (China) Limited Sovleplenib Phase 3 Study Meets..
07/08/202317:30UKREGHutchmed (China) Limited Exercise of Share Options by a..
31/07/202320:00UKREGHutchmed (China) Limited Interim Results and Business..
20/07/202315:00RNSNONHutchmed (China) Limited Breakthrough Therapy Designation..
13/07/202317:30UKREGHutchmed (China) Limited Changes to Board and Technical..
10/07/202315:00RNSNONHutchmed (China) Limited Phase 1 Study of HMPL-415 Initiated
29/06/202317:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
26/06/202317:30UKREGHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year..
16/06/202315:00UKREGHutchmed (China) Limited Phase III FRESCO-2 Results in The..
15/06/202323:39UKREGHutchmed (China) Limited MAA of Fruquintinib Validated by..
09/06/202318:30RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
06/06/202318:00UKREGHutchmed (China) Limited LTIP and Share Option Scheme
31/05/202317:30UKREGHutchmed (China) Limited Total Voting Rights
26/05/202315:00RNSNONHutchmed (China) Limited HUTCHMED Highlights Presentations..
26/05/202315:00UKREGHutchmed (China) Limited Fruquintinib NDA Granted Priority..
17/05/202317:30UKREGHutchmed (China) Limited Standard form for notification of..
12/05/202321:15UKREGHutchmed (China) Limited Annual General Meeting Poll Results
12/05/202317:30UKREGHutchmed (China) Limited Board of Directors and Board..
10/05/202317:30UKREGHutchmed (China) Limited Appointment of Independent NED

최근 히스토리

Delayed Upgrade Clock